This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Switching antidepressant (SSRIs to clomipramine) in adults

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

SSRIs to clomipramine

Cross-tapering is not recommended and should only be undertaken if specialist advice is in place, this is because clomipramine is a potent serotonin reuptake inhibitor so there is a high risk of serotonin syndrome.

From all except fluoxetine, fluvoxamine and paroxetine

  • Taper, stop and switch
    • gradually reduce the dose of the SSRI and stop. Start low dose clomipramine the following day

From fluoxetine

Taper, washout and switch

  • gradually reduce the dose of fluoxetine to 20mg daily and stop; wait 14 to 21 days before starting low dose clomipramine
    • clinicians should decide the duration of the washout period on a case-by-case basis
  • fluoxetine may still cause medicine interactions 5 or 6 weeks after stopping, as fluoxetine and its active metabolite have a long half-life
  • if switching from fluoxetine, caution is required as it is a potent inhibitor of the liver enzyme CYP2D6 which is involved in the metabolism of clomipramine
    • is therefore a risk of raised clomipramine levels in the body when switching

From fluvoxamine or paroxetine

Taper, stop and switch

  • gradually reduce the dose of fluvoxamine or paroxetine and stop. Start low dose clomipramine the following day.

Taper, washout and switch

  • alternatively, gradually reduce the dose of fluvoxamine or paroxetine and stop; wait for a period before starting clomipramine. Clinicians should decide the duration of the washout period on a case-by-case basis.

Additional caution

  • if switching from fluvoxamine or paroxetine, caution is required because fluvoxamine is a potent inhibitor of the liver enzyme CYP1A2, and paroxetine is a potent inhibitor of the liver enzyme CYP2D6; these enzymes are involved in the metabolism of clomipramine
    • is therefore a risk of raised clomipramine levels in the body when they are administered together

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.